公开(公告)号：US20050227429A1

公开(公告)日：2005-10-13

申请号：US10508460

申请日：2003-03-27

Applicant: Shozo Minamitani ,  Takaharu Mae ,  Yasuharu Ueno ,  Akira Yamada ,  Shinji Kanayama ,  Makoto Akita ,  Nobuhisa Watanabe ,  Akira Mori ,  Hiroyuki Naito ,  Shinya Marumo ,  Makoto Morikawa

Inventor： Shozo Minamitani ,  Takaharu Mae ,  Yasuharu Ueno ,  Akira Yamada ,  Shinji Kanayama ,  Makoto Akita ,  Nobuhisa Watanabe ,  Akira Mori ,  Hiroyuki Naito ,  Shinya Marumo ,  Makoto Morikawa

IPC: B23K20/10 ,  H01L21/00 ,  H01L21/8238

CPC classification number: H01L24/81 ,  B23K20/10 ,  B23K2101/40 ,  H01L21/67144 ,  H01L24/75 ,  H01L2224/75 ,  H01L2224/75252 ,  H01L2224/75355 ,  H01L2224/75743 ,  H01L2224/81205 ,  H01L2224/8121 ,  H01L2224/81222 ,  H01L2224/81224 ,  H01L2224/81815 ,  H01L2924/01005 ,  H01L2924/01033 ,  H01L2924/01047 ,  H01L2924/01082 ,  H01L2924/014 ,  H01L2924/12042 ,  H01L2924/14 ,  H01L2924/00

Abstract: A component mounting apparatus includes a component feeder (20) that feeds a component (2) with its bump electrodes facing down, a mounting head (5) that mounts the component onto a substrate (3), a supporting base (8) that secures the substrate, and a positioning device (6, 7) that aligns the component with the substrate. The mounting head includes an ultrasonic vibration generator (24), an ultrasonic vibration propagation member (34, 38, 54) that conveys the ultrasonic vibration provided by the ultrasonic vibration generator to a working face (33, 41, 57) holding the component as vibration parallel thereto, a pressure loader (22, 23, 39, 55, 59) that applies a pressure load to the working face from a position immediately thereabove in the direction perpendicular thereto, and a heater (32, 47, 49, 50, 51, 52, 53) that heats the vicinity of the working face. Thereby, ultrasonic bonding is carried out with high reliability even if the component has a number of bump electrodes (2a) on its face.

Abstract translation: 一种部件安装装置，包括：一个部件供给器（20），其部件（2）的凸起电极朝下;一个安装头（5），该部件安装在基板（3）上;支撑基座（8） 所述基板以及将所述部件与所述基板对准的定位装置（6,7）。 安装头包括超声波振动发生器（24），超声波振动传播部件（34,38,54），其将由超声波振动发生器提供的超声波振动传递到保持部件的工作面（33,41,57），如 振动平行的压力加载器（22,23,39,55,59），其从垂直于其垂直方向的上方的位置向工作面施加压力负荷;加热器（32,47,49,55,59） 51,52,53），其加热了工作面附近。 因此，即使该部件的面上具有多个凸块电极（2a），也可以高可靠性地进行超声波接合。

公开(公告)号：US20050179908A1

公开(公告)日：2005-08-18

申请号：US11052476

申请日：2005-02-08

Applicant: Hideo Wada ,  Nobuhisa Watanabe ,  Takayuki Taminaga

Inventor： Hideo Wada ,  Nobuhisa Watanabe ,  Takayuki Taminaga

IPC: G01S17/58 ,  G01B9/02 ,  G01B11/00 ,  G01F1/66 ,  G01P3/36

CPC classification number: G01P3/366 ,  G01F1/663

Abstract: Two different phase components obtained by splitting interference light of light from an object by a diffraction grating are guided to first and second PD's by a second optical system. A first signal is outputted from a first signal processing circuit section that receives light reception signal from first PD, and a second signal is outputted from a second signal processing circuit section that receives a light reception signal from the second PD. A third signal of an interference light signal whose noise component is removed is outputted by a third signal processing circuit section using the first signal and the second signal. Then, the frequency of the third signal is detected, and the movement velocity of the object is detected by a movement velocity detection section on the basis of the frequency.

Abstract translation: 通过衍射光栅将来自物体的光的干涉光分离而获得的两个不同相位分量被第二光学系统引导到第一和第二PD。 第一信号从接收来自第一PD的光接收信号的第一信号处理电路部分输出，并且从接收来自第二PD的光接收信号的第二信号处理电路部分输出第二信号。 噪声成分被除去的干涉光信号的第三信号由第三信号处理电路部分使用第一信号和第二信号输出。 然后，检测第三信号的频率，并且基于频率由移动速度检测部检测物体的移动速度。

公开(公告)号：US06699870B2

公开(公告)日：2004-03-02

申请号：US10281194

申请日：2002-10-28

Applicant: Nobuhisa Watanabe ,  Norio Karibe ,  Kazuki Miyazaki ,  Fumihiro Ozaki ,  Atsushi Kamada ,  Shuhei Miyazawa ,  Yoshimitsu Naoe ,  Toshihiko Kaneko ,  Itaru Tsukada ,  Tadashi Nagakura ,  Hiroki Ishihara ,  Kohtarou Kodama ,  Hideyuki Adachi

Inventor： Nobuhisa Watanabe ,  Norio Karibe ,  Kazuki Miyazaki ,  Fumihiro Ozaki ,  Atsushi Kamada ,  Shuhei Miyazawa ,  Yoshimitsu Naoe ,  Toshihiko Kaneko ,  Itaru Tsukada ,  Tadashi Nagakura ,  Hiroki Ishihara ,  Kohtarou Kodama ,  Hideyuki Adachi

IPC: A61K31502

CPC classification number: C07D231/12 ,  C07D233/56 ,  C07D237/28 ,  C07D237/34 ,  C07D249/08 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/06 ,  C07D409/14 ,  C07D411/14 ,  C07D417/04 ,  C07D417/14 ,  C07D451/06 ,  C07D471/08 ,  C07D491/04 ,  C07D491/08 ,  C07D491/10

Abstract: The present invention provides a phthalazine compound as a therapeutic agent for erectile dysfunction represented by the following formula, a pharmacologically acceptable salt thereof or a hydrate thereof: wherein R1 and R2 are the same as or different from each other and represent a halogen atom, a C1 to C4 alkyl group which may be substituted with a halogen atom, a C1 to C4 alkoxy group which may be substituted with a halogen atom or a cyano group; X represents a cyano group, a nitro group, a halogen atom, a hydroxyimino group which may be substituted or a heteroaryl group which may be substituted; Y represents a heteroaryl group, an aryl group which may be substituted, an alkynyl group which may substituted, an alkenyl group, an alkyl group, an optionally substituted saturated or unsaturated 4- to 8-membered amine ring, and the cyclic amine compound is a monocyclic compound, bicyclic compound or a spiro compound; l is an integer of 1 to 3; provided that the case where l is 1 or 2, X is a cyano group, a nitro group or a chlorine atom, R1 is a chlorine atom, R2 is a methoxy group and Y is a 5- or 6-memberred amine ring substituted with a hydroxyl group is excluded.

Abstract translation: 本发明提供作为下式表示的勃起功能障碍治疗剂的酞嗪化合物，其药理学上可接受的盐或其水合物：其中R 1和R 2彼此相同或不同， 可以被卤素原子取代的C1〜C4烷基，可被卤素原子或氰基取代的C1〜C4烷氧基; X表示氰基，硝基，卤素原子，可被取代的羟基亚氨基或可被取代的杂芳基; Y表示可以被取代的杂芳基，可以被取代的芳基，可以被取代的炔基，烯基，烷基，任选取代的饱和或不饱和的4-至8-元胺环，环胺化合物是 单环化合物，双环化合物或螺环化合物; l为1〜3的整数， 条件是其中l为1或2，X为氰基，硝基或氯原子，R 1为氯原子，R 2为甲氧基，Y为5-或6 被羟基取代的胺基环被排除。

公开(公告)号：US06329640B1

公开(公告)日：2001-12-11

申请号：US09690746

申请日：2000-10-18

Applicant: Shoriki Narita ,  Makoto Imanishi ,  Takaharu Mae ,  Nobuhisa Watanabe ,  Shinji Kanayama

Inventor： Shoriki Narita ,  Makoto Imanishi ,  Takaharu Mae ,  Nobuhisa Watanabe ,  Shinji Kanayama

IPC: F27B514

CPC classification number: H01L21/67103 ,  H01L21/68

Abstract: An object of the present invention is to provide a bump-bonding heating apparatus, a bump bonding method and a bump forming apparatus which do not involve large-sized apparatus configuration and which are easy to handle, and a semiconductor wafer in which bumps are formed by using the bump bonding method. The bump-bonding heating apparatus has a wafer turning member, a turning unit and a wafer heating unit. The turning member is turned by the turning unit without turning the wafer heating unit, whereby a semiconductor wafer mounted on the turning member is turned. Like this, since the wafer heating unit is not turned, the apparatus configuration can be made compact. Since the turning member is turned directly by the turning unit, the turning angle of the semiconductor wafer can be implemented with higher precision as compared with the conventional gas floating type turning method.

Abstract translation: 本发明的目的是提供一种不涉及大型装置结构并易于处理的凸块焊接加热装置，凸块接合方法和凸块形成装置以及形成凸块的半导体晶片 通过使用凸块接合方法。 凸点焊接加热装置具有晶片转动部件，转动部件和晶片加热部件。 转动构件在不转动晶片加热单元的情况下由转动单元转动，从而转动安装在转动构件上的半导体晶片。 像这样，由于晶片加热单元没有转动，所以可以使装置结构紧凑。 由于转动构件直接由转动单元转动，与常规气浮式转动方法相比，可以以更高的精度实现半导体晶片的转动角度。

公开(公告)号：US06288064B1

公开(公告)日：2001-09-11

申请号：US09202422

申请日：1999-02-16

Applicant: Nobuhisa Watanabe ,  Yasuhiro Kabasawa ,  Shinya Abe ,  Mayu Shibazaki ,  Hiroki Ishihara ,  Kohtarou Kodama ,  Hideyuki Adachi

Inventor： Nobuhisa Watanabe ,  Yasuhiro Kabasawa ,  Shinya Abe ,  Mayu Shibazaki ,  Hiroki Ishihara ,  Kohtarou Kodama ,  Hideyuki Adachi

IPC: A61K3150

CPC classification number: C07D237/34

Abstract: The present invnetion provides a remedy for erectile dysfunction. The active ingredient thereof is a fused pyridazine compound represented by the following formula (I) or a pharmacologically acceptable salt thereof: (wherein the ring C represents a 5 or 6 membered ring optionally having hetero atom(s); n is an integer of from 1 to 4; R1 represents a hydrogen, a halogen, a cyano, etc.; A represents a hydrogen, a halogen, an optionally substituted amino, etc.; X represents a group represented by the formula —N═, etc.; and Y represents the formula —CO—, an optionally substituted amino, etc).

Abstract translation: 本次入院为勃起功能障碍提供补救措施。 其活性成分是由下式（I）表示的稠合哒嗪化合物或其药理学上可接受的盐：（其中环C表示任选具有杂原子的5或6元环; n为 1至4; R 1表示氢，卤素，氰基等; A表示氢，卤素，任选取代的氨基等; X表示由式-N =等表示的基团;和 Y表示式-CO-，任选取代的氨基等）。

公开(公告)号：US5849741A

公开(公告)日：1998-12-15

申请号：US619621

申请日：1996-04-09

Applicant: Nobuhisa Watanabe ,  Yasuhiro Kabasawa ,  Yasutaka Takase ,  Fumihiro Ozaki ,  Keiji Ishibashi ,  Kazuki Miyazaki ,  Masayuki Matsukura ,  Shigeru Souda ,  Kazutoshi Miyake ,  Hiroki Ishihara ,  Kohtaro Kodama ,  Hideyuki Adachi

Inventor： Nobuhisa Watanabe ,  Yasuhiro Kabasawa ,  Yasutaka Takase ,  Fumihiro Ozaki ,  Keiji Ishibashi ,  Kazuki Miyazaki ,  Masayuki Matsukura ,  Shigeru Souda ,  Kazutoshi Miyake ,  Hiroki Ishihara ,  Kohtaro Kodama ,  Hideyuki Adachi

IPC: C07D237/34 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D471/04 ,  C07D521/00 ,  A01K31/50 ,  C07D237/30

CPC classification number: C07D231/12 ,  C07D233/56 ,  C07D237/34 ,  C07D249/08 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D471/04

Abstract: A fused pyridazine compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof which exhibits an inhibitory activity against cyclic GMP phosphodiesterase (hereinafter referred to as "cGMP-PDE"). The compounds are useful as preventive and therapeutic agents for diseases for which a cGMP-PDE inhibiting action is efficacious, for example, ischemic heart diseases such as angina pectoris, myocardial infarct and chronic and acute cardiac failure, pulmonary hypertension, arteriosclerosis and bronchial asthma. ##STR1##

Abstract translation: PCT No.PCT / JP95 / 01575 Sec。 371日期：1996年4月9日 102（e）日期1996年4月9日PCT提交1995年8月8日PCT公布。 出版物WO96 / 05176 日期：1996年2月22日由下述通式（I）表示的稠合哒嗪化合物或其对环状GMP磷酸二酯酶具有抑制活性的药理学上可接受的盐（以下称为“cGMP-PDE”）。 所述化合物可用作对于cGMP-PDE抑制作用有效的疾病的预防和治疗剂，例如心绞痛，心肌梗塞，慢性和急性心力衰竭，肺动脉高压，动脉硬化和支气管哮喘等缺血性心脏病。 （一）

公开(公告)号：US5693652A

公开(公告)日：1997-12-02

申请号：US408867

申请日：1995-03-23

Applicant: Yasutaka Takase ,  Nobuhisa Watanabe ,  Makoto Matsui ,  Hironori Ikuta ,  Teiji Kimura ,  Takao Saeki ,  Hideyuki Adachi ,  Tadakazu Tokumura ,  Hisatoshi Mochida ,  Yasunori Akita ,  Shigeru Souda

Inventor： Yasutaka Takase ,  Nobuhisa Watanabe ,  Makoto Matsui ,  Hironori Ikuta ,  Teiji Kimura ,  Takao Saeki ,  Hideyuki Adachi ,  Tadakazu Tokumura ,  Hisatoshi Mochida ,  Yasunori Akita ,  Shigeru Souda

IPC: C07D215/42 ,  A61K31/415 ,  A61K31/4184 ,  A61K31/4427 ,  A61K31/443 ,  A61K31/445 ,  A61K31/454 ,  A61K31/4706 ,  A61K31/4709 ,  A61K31/496 ,  A61K31/505 ,  A61K31/517 ,  A61K31/519 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  A61P9/12 ,  A61P11/06 ,  A61P37/00 ,  A61P43/00 ,  B60S1/16 ,  B60S1/24 ,  C07D215/48 ,  C07D235/06 ,  C07D235/08 ,  C07D239/78 ,  C07D239/84 ,  C07D239/86 ,  C07D239/88 ,  C07D239/90 ,  C07D239/94 ,  C07D239/95 ,  C07D239/96 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D413/12 ,  C07D471/04 ,  C07D491/04 ,  C07D491/056 ,  C07D521/00 ,  F16C7/02 ,  F16C11/04 ,  C07D235/04

CPC classification number: C07D235/06 ,  C07D215/42 ,  C07D231/12 ,  C07D233/56 ,  C07D239/84 ,  C07D239/86 ,  C07D239/88 ,  C07D239/94 ,  C07D239/95 ,  C07D239/96 ,  C07D249/08 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D413/10 ,  C07D413/12 ,  C07D471/04 ,  C07D491/04

Abstract: The present invention provides a nitrogenous heterocyclic compound represented by the following general formula (1) or a pharmacologically acceptable salt thereof which is useful for various ischemic heart diseases and the like: ##STR1## �in formula (1), ring A represents a benzene ring, a pyridine ring or a cyclohexane ring: ring B represents a pyridine ring, a pyrimidine ring or an imidazole ring, R.sup.1, R.sup.2, R.sup.3 R.sup.4, R.sup.5 and R.sup.6 are described herein.

Abstract translation: 本发明提供由以下通式（1）表示的含氮杂环化合物或其药理学上可接受的盐，其可用于各种缺血性心脏病等：（1）[式（1）中，环A 表示苯环，吡啶环或环己烷环：环B表示吡啶环，嘧啶环或咪唑环，R1，R2，R3，R4，R5和R6如本文所述。

公开(公告)号：US5630085A

公开(公告)日：1997-05-13

申请号：US082822

申请日：1993-06-28

Applicant: Nobuhisa Watanabe

Inventor： Nobuhisa Watanabe

IPC: G06F9/30 ,  G06F9/32 ,  G06F9/38

CPC classification number: G06F9/3802 ,  G06F9/321 ,  G06F9/383

Abstract: A microcomputer includes an instruction decoder and a program counter. The instruction decoder decodes fetched instructions and outputs a control signal ordering execution of the fetched instruction. The control signal from the instruction decoder includes a component controlling fetch cycles which triggers a fetch cycle at the beginning of each instruction cycle to fetch the operand for the instruction currently being executed and midway through each instruction cycle to fetch the OP code for the next instruction. The program counter is responsive to the triggering of each fetch cycle to increment its counter value so as to keep the counter value consistent with the address being accessed in each fetch cycle.

Abstract translation: 微型计算机包括指令解码器和程序计数器。 指令译码器解码取出的指令，并输出排序执行取指令的控制信号。 来自指令解码器的控制信号包括控制读取周期的部件，其触发在每个指令周期开始时的获取周期，以获取当前正在执行的指令的操作数，并在每个指令周期的中途获取下一个指令的OP代码 。 程序计数器响应于每个读取周期的触发以递增其计数器值，以便使计数值与每个读取周期中被访问的地址保持一致。

公开(公告)号：US07425634B2

公开(公告)日：2008-09-16

申请号：US11520838

申请日：2006-09-14

Applicant: Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

Inventor： Shuhei Miyazawa ,  Masanobu Shinoda ,  Tetsuya Kawahara ,  Nobuhisa Watanabe ,  Hitoshi Harada ,  Daisuke Iida ,  Hiroki Terauchi ,  Junichi Nagakawa ,  Hideaki Fujisaki ,  Atsuhiko Kubota ,  Masato Ueda

IPC: C07D401/12

CPC classification number: C07D491/04 ,  C07D405/14 ,  C07D493/08 ,  C07D493/10

Abstract: An object of the present invention is to provide a novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases, having an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability.Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

Abstract translation: 本发明的目的是提供一种新颖的化合物，其可用作酸性相关疾病的治疗或预防剂，对胃酸分泌具有优异的抑制作用，具有保持对胃酸分泌的抑制作用的优异效果，从而 长时间保持胃内pH高，并具有更多的安全性和适当的物理化学稳定性。 其中R 1和R 3可以相同或不同，表示氢原子或C1-C6烷基; R 5表示（5,5-二甲基-1,3-二恶烷-2-基）甲氧基，5,7-二氧杂螺[2.5]辛-6-基甲氧基，1,5,9 - 三氧杂螺[5.5]十一烷-3-基甲氧基或（2,2-二甲基-1,3-二恶烷-5-基）甲氧基; R 4，R 5，R 6和R 7表示氢原子，卤素原子，C 1 -C 6 烷基，C1-C6卤代烷基，C1-C6烷氧基或C1-C6卤代烷氧基; 和W 1表示单键，亚甲基或亚乙基，其盐或它们的溶剂合物。

公开(公告)号：US07417718B2

公开(公告)日：2008-08-26

申请号：US11589224

申请日：2006-10-30

Applicant: Hideo Wada ,  Nobuhisa Watanabe ,  Takayuki Taminaga

Inventor： Hideo Wada ,  Nobuhisa Watanabe ,  Takayuki Taminaga

IPC: G01B3/36

CPC classification number: G01S17/36 ,  G01S7/4913 ,  G01S7/4915 ,  G01S7/493

Abstract: In an optical distance measuring apparatus, a transmitter has a light-emitting device emitting an optical signal synchronized with a modulating signal having a predetermined repetition frequency, and a modulating signal generator outputting the modulating signal to the light-emitting device. A receiver has a photodetector receiving an optical beam reflected by an object to be measured and converting it to an electrical signal, a switch receiving the signal from the modulating signal generator and alternately choosing two channels for the electrical signal with a predetermined timing, and first and second storage sections storing electrical signals on the two channels. A signal processing section has a differential operation section performing a differential operation on electrical signals stored in the first and second storage sections, and a distance determining section determining a distance to the object on the basis of the result of the differential operation of the differential operation section.

Abstract translation: 在光学距离测量装置中，发射器具有发射与具有预定重复频率的调制信号同步的光信号的发光装置，以及将调制信号输出到发光装置的调制信号发生器。 接收机具有光电检测器，接收由待测物体反射的光束并将其转换为电信号，开关接收来自调制信号发生器的信号，并以预定定时交替地选择电信号的两个通道，第一 以及在两个通道上存储电信号的第二存储部分。 信号处理部分具有对存储在第一和第二存储部分中的电信号执行差分操作的差分操作部分，以及基于差分操作的差分操作的结果确定到物体的距离的距离确定部分 部分。